Related Articles
A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer
RELATIONSHIP BETWEEN RESPONSE RATE AND MEDIAN SURVIVAL IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - COMPARISON OF ONCONASE(R) WITH OTHER ANTICANCER AGENTS
Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.
Alternating hepatic arterial infusion and systemic chemotherapy for stage IV colorectal cancer with synchronous liver metastasis
Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer